186 related articles for article (PubMed ID: 38709176)
1. Tail length and E525K dilated cardiomyopathy mutant alter human β-cardiac myosin super-relaxed state.
Duno-Miranda S; Nelson SR; Rasicci DV; Bodt SML; Cirilo JA; Vang D; Sivaramakrishnan S; Yengo CM; Warshaw DM
J Gen Physiol; 2024 Jun; 156(6):. PubMed ID: 38709176
[TBL] [Abstract][Full Text] [Related]
2. Tail Length and E525K Dilated Cardiomyopathy Mutant Alter Human β-Cardiac Myosin Super-Relaxed State.
Duno-Miranda S; Nelson SR; Rasicci DV; Bodt SLM; Cirilo JA; Vang D; Sivaramakrishnan S; Yengo CM; Warshaw DM
bioRxiv; 2023 Dec; ():. PubMed ID: 38105932
[TBL] [Abstract][Full Text] [Related]
3. Dilated cardiomyopathy mutation E525K in human beta-cardiac myosin stabilizes the interacting-heads motif and super-relaxed state of myosin.
Rasicci DV; Tiwari P; Bodt SML; Desetty R; Sadler FR; Sivaramakrishnan S; Craig R; Yengo CM
Elife; 2022 Nov; 11():. PubMed ID: 36422472
[TBL] [Abstract][Full Text] [Related]
4. Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes.
Alamo L; Ware JS; Pinto A; Gillilan RE; Seidman JG; Seidman CE; Padrón R
Elife; 2017 Jun; 6():. PubMed ID: 28606303
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of force-pCa relation in
Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
[TBL] [Abstract][Full Text] [Related]
6. Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release.
Bodt SML; Ge J; Ma W; Rasicci DV; Desetty R; McCammon JA; Yengo CM
bioRxiv; 2023 Nov; ():. PubMed ID: 38014187
[TBL] [Abstract][Full Text] [Related]
7. Cardiac myosin super relaxation (SRX): a perspective on fundamental biology, human disease and therapeutics.
Schmid M; Toepfer CN
Biol Open; 2021 Feb; 10(2):. PubMed ID: 33589442
[TBL] [Abstract][Full Text] [Related]
8. Dilated cardiomyopathy myosin mutants have reduced force-generating capacity.
Ujfalusi Z; Vera CD; Mijailovich SM; Svicevic M; Yu EC; Kawana M; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
J Biol Chem; 2018 Jun; 293(23):9017-9029. PubMed ID: 29666183
[TBL] [Abstract][Full Text] [Related]
9. Direct detection of the myosin super-relaxed state and interacting-heads motif in solution.
Chu S; Muretta JM; Thomas DD
J Biol Chem; 2021 Oct; 297(4):101157. PubMed ID: 34481842
[TBL] [Abstract][Full Text] [Related]
10. Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil.
Tang W; Unrath WC; Desetty R; Yengo CM
J Biol Chem; 2019 Nov; 294(46):17314-17325. PubMed ID: 31578282
[TBL] [Abstract][Full Text] [Related]
11. Synthetic thick filaments: A new avenue for better understanding the myosin super-relaxed state in healthy, diseased, and mavacamten-treated cardiac systems.
Gollapudi SK; Yu M; Gan QF; Nag S
J Biol Chem; 2021; 296():100114. PubMed ID: 33234590
[TBL] [Abstract][Full Text] [Related]
12. Two Classes of Myosin Inhibitors, Para-nitroblebbistatin and Mavacamten, Stabilize β-Cardiac Myosin in Different Structural and Functional States.
Gollapudi SK; Ma W; Chakravarthy S; Combs AC; Sa N; Langer S; Irving TC; Nag S
J Mol Biol; 2021 Nov; 433(23):167295. PubMed ID: 34627791
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers.
Anderson RL; Trivedi DV; Sarkar SS; Henze M; Ma W; Gong H; Rogers CS; Gorham JM; Wong FL; Morck MM; Seidman JG; Ruppel KM; Irving TC; Cooke R; Green EM; Spudich JA
Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8143-E8152. PubMed ID: 30104387
[TBL] [Abstract][Full Text] [Related]
14. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain.
Huang W; Liang J; Yuan CC; Kazmierczak K; Zhou Z; Morales A; McBride KL; Fitzgerald-Butt SM; Hershberger RE; Szczesna-Cordary D
FEBS J; 2015 Jun; 282(12):2379-93. PubMed ID: 25825243
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Super-Relaxed State of Human Cardiac β-Myosin by Molecular Dynamics Simulations.
Li M; Hu Y; Wang Q
J Phys Chem B; 2024 Apr; 128(13):3113-3120. PubMed ID: 38516963
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
[TBL] [Abstract][Full Text] [Related]
17. The biochemically defined super relaxed state of myosin-A paradox.
Mohran S; Kooiker K; Mahoney-Schaefer M; Mandrycky C; Kao K; Tu AY; Freeman J; Moussavi-Harami F; Geeves M; Regnier M
J Biol Chem; 2024 Jan; 300(1):105565. PubMed ID: 38103642
[TBL] [Abstract][Full Text] [Related]
18. Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin.
McNamara JW; Singh RR; Sadayappan S
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11731-11736. PubMed ID: 31142654
[TBL] [Abstract][Full Text] [Related]
19. Myosin dilated cardiomyopathy mutation S532P disrupts actomyosin interactions, leading to altered muscle kinetics, reduced locomotion, and cardiac dilation in
Trujillo AS; Hsu KH; Puthawala J; Viswanathan MC; Loya A; Irving TC; Cammarato A; Swank DM; Bernstein SI
Mol Biol Cell; 2021 Aug; 32(18):1690-1706. PubMed ID: 34081531
[TBL] [Abstract][Full Text] [Related]
20. MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
McNamara JW; Li A; Lal S; Bos JM; Harris SP; van der Velden J; Ackerman MJ; Cooke R; Dos Remedios CG
PLoS One; 2017; 12(6):e0180064. PubMed ID: 28658286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
